Renal cell carcinoma: Difference between revisions

Jump to navigation Jump to search
Line 45: Line 45:
==Treatment==
==Treatment==
[[Kidney cancer medical therapy|Medical therapy]] | [[Kidney cancer surgery|Surgical options]] | [[Kidney cancer primary prevention|Primary prevention]]  | [[Kidney cancer secondary prevention|Secondary prevention]] | [[Kidney cancer cost-effectiveness of therapy|Financial costs]] | [[Kidney cancer future or investigational therapies|Future therapies]]
[[Kidney cancer medical therapy|Medical therapy]] | [[Kidney cancer surgery|Surgical options]] | [[Kidney cancer primary prevention|Primary prevention]]  | [[Kidney cancer secondary prevention|Secondary prevention]] | [[Kidney cancer cost-effectiveness of therapy|Financial costs]] | [[Kidney cancer future or investigational therapies|Future therapies]]
==Prognosis==
The outcome varies depending on the size of the tumor, whether it is confined to the kidney or not, and the presence or absence of metastatic spread. The Furhman grading, which measures the aggressiveness of the tumor, may also affect survival, though the data is not as strong to support this.
The [[five year survival rate]] is around 90-95% for tumors less than 4 cm. For larger tumors confined to the kidney without venous invasion, survival is still relatively good at 80-85%. For tumors that extend through the renal capsule and out of the local fascial investments, the survivability reduces to near 60%. If it has metastasized to the lymph nodes, the 5-year survival is around 5 % to 15 %. If it has spread metastatically to other organs, the 5-year survival rate is less than 5 %.
For those that have tumor recurrence after surgery, the prognosis is generally poor.  Renal cell carcinoma does not generally respond to [[chemotherapy]] or [[radiation]].  [[Immunotherapy]], which attempts to induce the body to attack the remaining cancer cells, has shown promise.  Recent trials are testing newer agents, though the current complete remission rate with these approaches are still low, around 12-20% in most series.


==See also==
==See also==

Revision as of 17:13, 17 January 2012

For patient information click here

Template:DiseaseDisorder infobox

Kidney cancer Microchapters

Home

Patient Info

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Kidney cancer

Differentiating Kidney cancer from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Renal cell carcinoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma

CDC on Renal cell carcinoma

Renal cell carcinoma in the news

Blogs on Renal cell carcinoma

Directions to Hospitals Treating Kidney cancer

Risk calculators and risk factors for Renal cell carcinoma

Steven C. Campbell, M.D., Ph.D.

Contributors: C. Michael Gibson, M.S., M.D., Cafer Zorkun M.D., PhD.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms and Key Words: RCC, renal cell, renal cell CA, renal cell carcinoma, kidney cancer, kidney carcinoma, kidney CA, Grawitz tumor, hypernephroma

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Kidney cancer

Complications, & Prognosis

Diagnosis

History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics

Treatment

Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies

See also

External links

References

Template:Tumors Template:Nephrology Template:Tumor morphology Template:SIB

bs:Rak bubrega de:Nierenkrebs hr:Rak bubrega it:Cancro del rene fi:Munuaissyöpä sv:Njurcancer


Template:WikiDoc Sources